IMPACT OF SMOKING STATUS ON CLINICAL OUTCOMES WITH PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS TRIAL

被引:1
|
作者
Cornel, J. H.
Ohman, E. Magnus
Neely, Benjamin
Clemmensen, Peter
Sritara, Piyamitr
Zamoryakhin, Dmitry
Armstrong, Paul
Prabhakaran, Dorairaj
White, Harvey
Fox, Keith
Gurbel, Paul
Roe, Matthew
机构
[1] Duke Clin Res Inst, Durham, NC USA
[2] Med Ctr Alkmaar, Alkmaar, Netherlands
关键词
D O I
10.1016/S0735-1097(13)60160-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E159 / E159
页数:1
相关论文
共 50 条
  • [21] Prasugrel versus clopidogrel in patients with acute coronary syndromes.: Results of the TRITON-TIMI 38 trial
    Preohrazhensky, D. V.
    KARDIOLOGIYA, 2008, 48 (08) : 72 - 73
  • [22] Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization The TRILOGY ACS Trial
    Lopes, Renato D.
    Leonardi, Sergio
    Neely, Benjamin
    Neely, Megan L.
    Ohman, E. Magnus
    Ardissino, Diego
    Hamm, Christian W.
    Goodman, Shaun G.
    Bhatt, Deepak L.
    White, Harvey D.
    Prabhakaran, Dorairaj
    Martinez, Felipe
    Nicolau, Jose C.
    Winters, Kenneth J.
    Fox, Keith A. A.
    Armstrong, Paul W.
    Roe, Matthew T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (11) : 1289 - 1297
  • [23] Relationship between troponin levels and long-term outcomes in medically managed patients with non-ST-segment elevation acute coronary syndromes: insights from the TRILOGY ACS trial
    Newby, L. K.
    Ohman, E. M.
    Cyr, D.
    Neely, M.
    Roe, M.
    Luscher, T.
    Brown, E.
    White, H.
    Hamm, C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1162 - 1162
  • [24] Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
    Faggioni, M.
    Chandrasekhar, J.
    Baber, U.
    Sartori, S.
    Aquino, M.
    Rao, S.
    Weintraub, W.
    Effron, M.
    Baker, B.
    Danias, G.
    Pocock, S.
    Kapadia, S.
    Toma, C.
    Mehran, R.
    Henry, T.
    EUROPEAN HEART JOURNAL, 2016, 37 : 379 - 379
  • [25] Morphine/Clopidogrel Interaction and Cardiovascular Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes - Insights From EARLY-ACS Trial
    Furtado, Remo H.
    Nicolau, Jose C.
    Newby, Kristin L.
    Guo, Jianping W.
    Sabatine, Marc S.
    Giugliano, Robert P.
    CIRCULATION, 2018, 138
  • [26] Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)
    Hinohara, Tomoya T.
    Roe, Matthew T.
    White, Harvey D.
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Hamm, Christian
    Gurbel, Paul A.
    Aylward, Philip E.
    Wiviott, Stephen D.
    Huber, Kurt
    Neely, Megan L.
    Ohman, E. Magnus
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (08): : 1322 - 1329
  • [27] Outcomes in Women Compared With Men in Patients With Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction Managed Without Revascularization: Insights From the TRILOGY ACS Trial
    Clemmensen, Peter
    Roe, Matthew T.
    Hochman, Judith S.
    Cyr, Derek D.
    Neely, Megan L.
    McGuire, Darren K.
    Cornel, Jan H.
    Huber, Kurt
    Zamoryakhin, Dmitry
    White, Harvey D.
    Armstrong, Paul W.
    Fox, Keith A.
    Prabhakaran, Dorairaj
    Ohman, E. M.
    CIRCULATION, 2013, 128 (22)
  • [28] Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
    Kaul, Padma
    Ohman, E. Magnus
    Knight, J. David
    Anstrom, Kevin J.
    Roe, Matthew T.
    Boden, William E.
    Hochman, Judith S.
    Gasparovic, Vladimir
    Armstrong, Paul W.
    McCollam, Patrick
    Fakhouri, Walid
    Cowper, Patricia
    Davidson-Ray, Linda
    Clapp-Channing, Nancy
    White, Harvey D.
    Fox, Keith A. A.
    Prabhakaran, Dorairaj
    Mark, Daniel B.
    AMERICAN HEART JOURNAL, 2016, 178 : 55 - 64
  • [29] PREDICTORS OF PLATELET REACTIVITY ON PRASUGREL AND THEIR IMPACT ON CLINICAL OUTCOMES: INSIGHTS FROM THE TROPICAL ACS RANDOMIZED TRIAL
    Aradi, Daniel
    Komocsi, Andras
    Merkely, Bela
    Kiss, Robert
    Hadamitzky, Martin
    Massberg, Steffen
    Rizas, Konstantinos
    Gross, Lisa
    Hein-Rothweiler, Ralph
    Trenk, Dietmar
    Sibbing, Dirk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1398 - 1398
  • [30] Prasugrel versus clopidogrel in Asian patients with acute coronary syndromes: design and rationale of a multi-dose, pharmacodynamic, phase 3 clinical trial
    Ge, Junbo
    Zhu, Junren
    Hong, Bum-Kee
    Boonbaichaiyapruck, Sarana
    Goh, Yew Seong
    Hou, Charles Jia-Yin
    Pinton, Philippe
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (09) : 2077 - 2085